3-(n-maleimidopropionyl)biocytin has been researched along with Chronic Fatigue and Immune Dysfunction Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Iwase, M; Kuratsune, H; Mizuno, K; Nakatsuka, D; Onoe, H; Ouchi, Y; Tahara, T; Tajima, S; Tsukada, H; Watanabe, Y; Yamaguti, K; Yamamoto, S; Yoshikawa, E | 1 |
1 other study(ies) available for 3-(n-maleimidopropionyl)biocytin and Chronic Fatigue and Immune Dysfunction Syndrome
Article | Year |
---|---|
Reduction of [11C](+)3-MPB binding in brain of chronic fatigue syndrome with serum autoantibody against muscarinic cholinergic receptor.
Topics: Acetylcholinesterase; Adult; Autoantibodies; Brain Mapping; Carbon Radioisotopes; Fatigue Syndrome, Chronic; Female; Humans; Lysine; Magnetic Resonance Imaging; Male; Maleimides; Receptors, Muscarinic; Tomography, Emission-Computed | 2012 |